Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies
PharmaTalkRadio18 Jan 2023

Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies

In this talk, first recorded at the 2022 IO360° Summit, Dr Rachel Haurwitz, CEO, Caribou Biosciences, addresses the big picture view of where the cell therapy field is going and how innovative CRISPR-based editing will help with the treatment of hematologic and solid tumors. Key topics include: Approach that requires highly specific and efficient multiplex genome editingWhat are some of the potential stumbling blocks?What are the tools for solving those challenges?Tackling solid tumors as the next frontier for cell therapies Rachel Haurwitz, PhD, President & CEO, Caribou Biosciences Learn more about the IO360° Summit at www.io360summit.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
hacka-livet
bildningspodden
rss-vetenskapsradion
medicinvetarna
rss-ufobortom-rimligt-tvivel
sexet
ufo-sverige
rss-vetenskapsradion-2
halsorevolutionen
paranormalt-med-caroline-giertz
svd-nyhetsartiklar
det-morka-psyket
vetenskapsradion
ufo-sverige-2
rss-spraket
dumforklarat
rss-kriminologerna